NasdaqGM - Delayed Quote USD
Anbio Biotechnology Class A Ordinary Shares (NNNN)
6.43
+0.14
+(2.23%)
At close: May 2 at 4:00:00 PM EDT
6.43
-0.03
(-0.46%)
After hours: May 2 at 4:05:11 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
2,080.39
2,080.39
898.37
4,448.85
4,181.33
Investing Cash Flow
337.10
337.10
1,730.17
-1,527.90
--
Financing Cash Flow
-344.61
-344.61
-42.84
--
--
End Cash Position
11,760.86
11,760.86
9,687.98
7,102.27
4,181.33
Free Cash Flow
2,080.39
2,080.39
898.37
4,448.85
4,181.33
12/31/2021 - 2/19/2025
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
5YI.F Nyxoah SA
5.18
-0.19%
SRT4.F Sartorius Aktiengesellschaft
36.60
-0.54%
BPCINS.ST BPC Instruments AB
40.50
-3.11%
UTMD Utah Medical Products, Inc.
52.66
+0.88%
KMTS Kestra Medical Technologies, Ltd. Common Stock
23.75
+3.44%
MLSS Milestone Scientific Inc.
1.0900
+0.93%
FEMY Femasys Inc.
1.1600
-1.69%
COO The Cooper Companies, Inc.
82.30
+1.43%
ZTEK Zentek Ltd.
1.7800
+0.56%
XRAY DENTSPLY SIRONA Inc.
14.08
+1.08%